Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | MCHR1 | Q99705 | 5/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26604713 | 1.00 | RAB9A (0.59) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL26604699 | 0.91 | KDM4E (0.53) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL31683201 | 0.91 | KDM4E (0.53) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL26604695 | 0.90 | KDM4E (0.52) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL26604710 | 0.90 | MCHR1 (0.50) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL26604693 | 0.89 | KDM4E (0.64) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL31683094 | 0.88 | L3MBTL1 (0.54) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL26604709 | 0.88 | L3MBTL1 (0.54) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL31683150 | 0.88 | MAPT (0.57) | RAB9ASMN1; SMN2KDM4EPOLBLMNA | |
| SCHEMBL26604754 | 0.88 | MAPT (0.57) | RAB9ASMN1; SMN2KDM4EPOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283038-A1 | COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2025-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250283038-A1 | COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS | CXCL10, IL2, IFNG | RAB9A 1593/4885SMN1; SMN2 4812/4885KDM4E 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.